Navigation Links
BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
Date:10/21/2009

INDIANAPOLIS, Oct. 21 /PRNewswire/ -- BioStorage Technologies, Inc., a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, will expand its European operations with the opening of a new 16,140 square foot (1,499 sq meters) full-service biorepository in Frankfurt, Germany.

BioStorage Technologies' expanded European operations is part of the company's strategic growth plan to accommodate a rapidly growing list of customers based in Europe. The new facility will offer worldwide, industry-compliant logistics, supply chain management and will meet all international customs and transportation regulations as well as documentation requirements. The company will begin offering services effective immediately.

"We are pleased to see such rapid global growth since opening our initial Germany-based facility in 2007," said F. John Mills, M.D., Ph.D., chief executive officer and chairman of the board at BioStorage Technologies. "Frankfurt has been an ideal location for us to create additional alliances and partnerships with companies conducting pharmaceutical research and development in Europe."

The expansion comes on the heels of BioStorage Technologies' announcement that it will create 125 new jobs in the United States by expanding its global headquarters in Indianapolis to include an additional 40,000 square foot cold-storage facility.

"Our strategic, centralized locations next to two of the largest freight hubs in the world give us the unique capability to ship critical, temperature-sensitive biomaterials and clinical trial supplies to any of our customer's locations worldwide with exceptional expediency," adds Mills.

Dr. Wolfgang Hoffer, managing director of BioStorage Technologies' European operations asserts, "The extension of our services in Europe will reinforce the scope and depth of significant biomedical and pharmaceutical research conducted by our clients in this part of the world," said Hoffer.

BioStorage Technologies' newest biorepository will continue to serve pharmaceutical and biotech firms, donor organizations and banks as well as research and academic organizations based in Europe. The new facility will feature the same unparalleled sample management services, assets and standard operating procedures currently offered at all the company's facilities.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries. The company offers secure, temperature-controlled storage, real-time tracking of stored biological samples, and next-day return of biomaterials. BioStorage Technologies, Inc. is privately-held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1010.

    Press Contact:
    Michael Clark
    Miller Brooks, Inc.
    317-873-8100
    michael@millerbrooks.com

SOURCE BioStorage Technologies, Inc.


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
2. Blue Belt Technologies, Inc. Closes Series A Financing
3. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
4. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
5. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
6. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
7. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
8. Wound Management Technologies, Inc. Announces Evidence Based Study
9. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
10. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Feb 27, 2017 Period October – December 2016 ... Operating result amounted to SEK -16.4 (-6.4) million Result after ... (-0.22) before and after dilution Cash flow from operating activities ... ... 0.4 (0.4) million Operating result amounted to SEK -39.5 (-29.5) ...
(Date:2/24/2017)... , Feb. 24, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... a CAGR of around 23.8% over the next decade to reach ... the market estimates and forecasts for all the given segments on ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 26, 2017 , ... Today, A' Design Awards & Competition ... Social Design Awards. , The 7th A' Social Design Award is open ... worldwide with realized projects and conceptual works. , The first phase of the ...
(Date:2/26/2017)... , ... February 26, 2017 ... ... a new technology standard in staffing, scheduling, and reporting for healthcare organizations. ... predict activity throughout the entire staffing process. StaffBridge technology improves staffing efficiency, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Liberty University, has officially announced the appointment of Peter A. Bell, DO, MBA, ... Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to Liberty from ...
(Date:2/24/2017)... ... 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ... his paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles ... , Schanssema, initially unsure of the career path he wanted to take, found fulfillment ...
Breaking Medicine News(10 mins):